|
Belyaeva V.V., Adigamov M.M.
Awareness about the modes of human immunodeficiency virus transmission and a stigmatizing attitude: Results of a survey of military-aged men
|
№3 / 2017
|
|
Sizova N.V., Korneeva T.S., Bratkova V.V., Sotnikova A.L., Rassokhin V.V.
Combined antiretroviral drugs containing lamivudine and zidovudine for the treatment of HIV infection
|
№1 / 2017
|
|
Ruziev M.M.
Specific features of the spread of HIV infection among persons who inject drugs in the Republic of Tajikistan
|
№1 / 2017
|
|
Belyaeva V.V., Adigamov M.M.
Prevention of human immunodeficiency virus infection: awareness, perceptions of individual risk of contamination, change in behavior
|
№6 / 2016
|
|
Ivanova E.S.
Phosphaside and lamivudine as a nucleoside base of first-line antiretroviral therapy regimens for HIV infection
|
№4 / 2016
|
|
Eremeeva Zh.G., Yakupova F.M., Turaev R.G., Fazylov V.Kh.
Infection safety of donor blood: Relevance of HBV testing
|
№4 / 2016
|
|
Belyaeva V.V., Adigamov M.M., Orlova M.O., Sokolova E.V.
Comparative analysis of the features of stigmatization of different social diseases
|
№4 / 2016
|
|
Kulabukhova E.I., Kravchenko A.V., Zimina V.N., Pokrovskaya A.V.
Genetic markers for HIV infection progression and secondary diseases development
|
№3 / 2016
|
|
Podymova A.S.
Development of low-threshold access to examination for HIV infection in the Sverdlovsk Region
|
№3 / 2016
|
|
Plotnikova Yu.K., Ponomareva O.A., Revizor A.O., Kruglova E.A.
Analysis of the spread of drug resistance mutations in the HIV-1 pol gene among the HIV-infected in the Irkutsk Region
|
№3 / 2016
|
|
Kanestri V.G., Yagodkin М.V.
Use of non-boosted atazanavir in clinical practice
|
№2 / 2016
|
|
Kravchenko A.V., Kanestri V.G.
HIV drug resistance: Dolutegravir is a second-generation HIV integrase inhibitor
|
№6 / 2015
|
Русский
